Skip to main content

Table 2 Perioperative data between two groups

From: Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy

Variable

No diabetes (n = 134)

Diabetes (n = 67)

p value

Concomitant procedures

 Mitral valve procedure, n

22 (16.4%)

9 (13.4%)

0.58

 Tricuspid valvuloplasty, n

15 (11.2%^)

7 (10.4%)

0.87

 CABG, n

6 (4.5%)

8 (11.9%)

0.05

 Maze procedure, n

5 (3.7%)

8 (11.9%)

0.03

 Cardiopulmonary bypass time, min

107.6 ± 47.1

113.3 ± 51.2

0.43

 Aortic crossclamping time, min

72.7 ± 36.4

76.8 ± 35.9

0.45

 Postoperative ventilation time, min

17.0 (13.0–21.0)

17.0 (13.0–24.0)

0.98

 Postoperative hospital stays, day

8.4 ± 3.8

8.4 ± 4.2

0.96

 Post-operative LVOT gradient, mmHg

6.6 ± 2.7

7.6 ± 3.4

0.04

 Perioperative death

0 (0.0%)

1 (1.5%)

0.33

  1. Values are presented as percentage, mean ± SD, or median (interquartile range) when appropriate
  2. CABG coronary artery bypass graft, ICU intensive care unit